• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acceleron Pharma Inc

+ Add to Watchlist

XLRN:US

38.4100 USD 0.6100 1.61%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Acceleron Pharma Inc (XLRN)

Open: 38.0200 Day's Range: 37.7000 - 39.2796 Volume: 224,555
Previous Close: 37.8000 52wk Range: 15.0000 - 57.8900 1-Yr Rtn: -

Stock Chart for XLRN

No chart data available.
  • XLRN:US 38.4100
  • 1D
  • 1M
  • 1Y
37.8000
Interactive XLRN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XLRN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -5.1870
Est. EPS (USD) (12/2014) -1.3820
Est. PEG Ratio -
Market Cap (M USD) 1,196.87
Shares Outstanding (M) 31.16
30 Day Average Volume 350,386
Price/Book (mrq) 18.8347
Price/Sale (ttm) 2.0896
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/27/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XLRN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for XLRN

Acceleron Pharma, Inc. provides pharmaceutical products. The Company focuses on discovering, developing, manufacturing, and marketing of protein therapeutics for cancer and orphan diseases. Acceleron Pharma serves patients throughout the United States.

John L KnopfPresident/CEO/Co-FounderKevin F McLaughlinSenior VP/CFO/Treasurer
Matthew L ShermanSenior VP/Chief Medical OfcrSteven ErtelSenior VP/Chief Business Ofcr
More Company Profile & Key Executives for XLRN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil